All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY2151 | Anti-MEF2A (CBFYM-2022) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2022 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2152 | Anti-MEF2A (CBFYM-2023) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2023 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2153 | Anti-MEF2A (CBFYM-2024) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2024 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2154 | Anti-MEF2A (CBFYM-2025) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBFYM-2025 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5404 | Anti-MEF2A (CBFYM-2022) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2022 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5405 | Anti-MEF2A (CBFYM-2023) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2023 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5406 | Anti-MEF2A (CBFYM-2024) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-2024 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5407 | Anti-MEF2A (CBFYM-2025) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBFYM-2025 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION